Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,282,064
-
Share change
-
+2,137,772
-
Total reported value
-
$69,065,474
-
Put/Call ratio
-
270%
-
Price per share
-
$5.20
-
Number of holders
-
62
-
Value change
-
+$12,019,529
-
Number of buys
-
37
-
Number of sells
-
22
Institutional Holders of MIRATI THERAPEUTICS INC - COM (MRTX) as of Q1 2017
As of 31 Mar 2017,
MIRATI THERAPEUTICS INC - COM (MRTX) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,282,064 shares.
The largest 10 holders included
venBio Select Advisor LLC, BAKER BROS. ADVISORS LP, Broadfin Capital, LLC, Boxer Capital, LLC, BlackRock Inc., Hillhouse Capital Management, Ltd., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Alyeska Investment Group, L.P., and SABBY MANAGEMENT, LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.